Acquired Resistance to Targeted Therapies Against Oncogene-Driven Non–Small-Cell Lung Cancer: Approach to Subtyping Progressive Disease and Clinical Implications-Reference-Cited by-同舟云学术

Acquired Resistance to Targeted Therapies Against Oncogene-Driven Non–Small-Cell Lung Cancer: Approach to Subtyping Progressive Disease and Clinical Implications

Published:2014-01 Issue:1 Volume:15 Page:1-6
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Gandara David R.,Li Tianhong,Lara Primo N.,Kelly Karen,Riess Jonathan W.,Redman Mary W.,Mack Philip C.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference36 articles.

1. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing;Imielinski;Cell,2012

2. Comprehensive genomic characterization of squamous cell lung cancer;Nature,2012

3. Personalized oncology through integrative high-throughput sequencing: a pilot study;Roychowdhury;Sci Transl Med,2011

4. Genotyping and genomic profiling of non–small-cell lung cancer: implications for current and future therapies;Li;J Clin Oncol,2013

5. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N Engl J Med,2004

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Treatment Patterns, Health Outcomes, and Healthcare Resource Use in Advanced Common EGFR-Positive Non-Small Cell Lung Cancer Patients Treated with Osimertinib in Alberta;Current Oncology;2024-07-31

2. Update in Precision Oncology in Non-small Cell Lung Cancer;International Journal of Cancer Care and Delivery;2024-02-28

3. Best practices in epidermal growth factor receptor T790M testing for advanced non–small-cell lung cancer in Hong Kong;Hong Kong Medical Journal;2023-06-21

4. Single-Droplet Microsensor for Ultra-Short Circulating EFGR Mutation Detection in Lung Cancer Based on Multiplex EFIRM Liquid Biopsy;International Journal of Molecular Sciences;2023-06-20

5. Small Molecule Inhibitors as Therapeutic Agents Targeting Oncogenic Fusion Proteins: Current Status and Clinical;Molecules;2023-06-09